BIOINFORMATICS SEMINAR SERIES
December 5, 2022
Ammon-Pinizzotto Biopharmaceutical Innovation (BPI) Building
Conference Room 140
Personalized Medicine: Will It Work for Decreasing Age Related Morbidities?
Assistant Professor, Neurovascular aging lab, Kinesiology and Applied Physiology, UD
Recent work over the past several decades has identified the key molecular “hallmarks of aging.” These discoveries have paved the way for novel lifestyle and pharmacological strategies for improving human health span. However, not all therapies are likely to work for every person. The most effective strategies for improving human health span will likely come from the convergence of two rapidly emerging fields of study: GeroScience—devoted to understanding the molecular mechanisms of aging in order to slow its progression, and Personalized Medicine—devoted to creating tailored treatments based on individual patient characteristics. This seminar will focus on the potential of personalized medicine for creating individualized treatments for preventing or reversing the biological mechanisms of aging and will also highlight some of the possible barriers to its implementation.
Christopher Martens is an Assistant Professor of Kinesiology & Applied Physiology at the University of Delaware and Director of the Delaware Center for Cognitive Aging Research (DECCAR). His research is focused on understanding how biological aging leads to increased risk of chronic disease, with an emphasis on cardiovascular and neurodegenerative diseases. He is currently funded by the National Institute on Aging to investigate the efficacy of a compound called nicotinamide riboside for improving memory and vascular function in older adults with mild cognitive impairment (MCI), a prodromal form of Alzheimer’s disease.